Simplex Trading
RNAC icon

Simplex Trading’s Cartesian Therapeutics RNAC Stock Holding History

Simplex Trading’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.54K Buy
+900
New +$6.41K ﹤0.01% 7827
2024
Q1 		– Sell
-283
Closed -$2K – 9712
2023
Q4 		$2K Buy
+283
New +$8.45K ﹤0.01% 8336
2022
Q4 		– Sell
-4,130
Closed -$203K – 10223
2022
Q3 		$203K Sell
4,130
-1,097
-21% -$60.3K ﹤0.01% 4585
2022
Q2 		$205K Buy
5,227
+3,417
+189% +$101K ﹤0.01% 4567
2022
Q1 		$66K Sell
1,810
-150
-8% -$9.38K ﹤0.01% 6747
2021
Q4 		$191K Buy
1,960
+453
+30% +$48.7K ﹤0.01% 5270
2021
Q3 		$197K Hold
1,507
– – ﹤0.01% 5611
2021
Q2 		$188K Buy
1,507
+1,503
+37,575% +$179K ﹤0.01% 5779
2021
Q1 		$50K Buy
+4
New +$497 ﹤0.01% 6625
2020
Q3 		– Sell
-4
Closed -$36K – 8385
2020
Q2 		$36K Buy
4
+2
+100% +$181 ﹤0.01% 5777
2020
Q1 		$12K Buy
+2
New +$193 ﹤0.01% 6359
2019
Q3 		– Sell
-1
Closed -$5K – 7781
2019
Q2 		$5K Hold
1
– – ﹤0.01% 6476
2019
Q1 		$9K Buy
+1
New +$63 ﹤0.01% 6223
2018
Q4 		– Hold
0
– -$4K – 7679
2018
Q3 		– Hold
0
– – – 6862
2018
Q2 		– Hold
0
– – – 7052

Other funds holding RNAC

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's RNAC Position: Q4 2023 in Review

Simplex Trading sold out of Cartesian Therapeutics (RNAC) in Q4 2023, closing a stake of 7 shares — an estimated $209 sold.

Simplex Trading first reported a position in RNAC in Q1 2018 and held it in 17 quarters. The position peaked at $243K in Q1 2021. 80 funds tracked by Wall St. Rank hold RNAC as of Q4 2023.

  • Simplex Trading reported no remaining Cartesian Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Simplex Trading sold 7 Cartesian Therapeutics shares in Q4 2023, an estimated $209.
  • Simplex Trading first reported a position in Cartesian Therapeutics in Q1 2018 and held it in 17 quarters.
  • Simplex Trading's Cartesian Therapeutics position peaked at $243K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.